Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,157 | 120 | 99.6% |
| Education | $13.89 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $455.86 | 18 | $0 (2024) |
| Lilly USA, LLC | $408.23 | 12 | $0 (2024) |
| Corcept Therapeutics | $381.22 | 19 | $0 (2024) |
| Dexcom, Inc. | $317.84 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $316.67 | 8 | $0 (2024) |
| Amgen Inc. | $263.09 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $153.90 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $122.76 | 1 | $0 (2017) |
| Xeris Pharmaceuticals, Inc. | $103.72 | 6 | $0 (2024) |
| BETA BIONICS, INC. | $100.36 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,431 | 55 | Lilly USA, LLC ($355.40) |
| 2023 | $1,058 | 46 | Novo Nordisk Inc ($253.62) |
| 2022 | $354.80 | 13 | SANOFI-AVENTIS U.S. LLC ($138.32) |
| 2021 | $149.53 | 4 | SANOFI-AVENTIS U.S. LLC ($90.69) |
| 2020 | $11.61 | 1 | W. L. Gore & Associates, Inc. ($11.61) |
| 2017 | $165.27 | 2 | Novartis Pharmaceuticals Corporation ($122.76) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Automated insulin delivery system | ||||||
| 12/29/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Automated insulin delivery system | ||||||
| 12/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Biological | ||||||
| 10/30/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $110.08 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Endocrinology | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $20.77 | General |
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Endocrinology | ||||||
| 09/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $95.36 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEPHROLOGY | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 58 | $17,980 | $4,834 |
| 2021 | 7 | 304 | 479 | $207,035 | $38,956 |
| 2020 | 14 | 572 | 788 | $321,432 | $54,302 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 42 | $11,340 | $3,130 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,640 | $1,704 | 25.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 113 | 258 | $109,455 | $21,260 | 19.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 63 | 70 | $27,237 | $5,896 | 21.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 64 | $22,288 | $3,715 | 16.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $12,470 | $2,863 | 23.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $12,495 | $2,031 | 16.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 31 | 31 | $10,943 | $1,802 | 16.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 24 | 24 | $12,147 | $1,389 | 11.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 98 | 217 | $60,685 | $12,931 | 21.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 77 | 132 | $64,026 | $11,424 | 17.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 94 | 99 | $29,584 | $5,831 | 19.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 95 | 117 | $31,590 | $5,212 | 16.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 28 | 28 | $24,744 | $4,973 | 20.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 21 | 21 | $38,493 | $3,394 | 8.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 42 | 50 | $30,560 | $3,093 | 10.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 28 | 30 | $6,090 | $1,753 | 28.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Facility | 2020 | 21 | 21 | $4,599 | $1,471 | 32.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $4,616 | $1,174 | 25.4% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 11 | 13 | $13,442 | $1,136 | 8.4% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 11 | 13 | $7,129 | $804.28 | 11.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 13 | 14 | $1,848 | $568.41 | 30.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 22 | 22 | $4,026 | $538.05 | 13.4% |
About Israa Ali
Israa Ali is a Internal Medicine healthcare provider based in League City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1841687720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Israa Ali has received a total of $3,171 in payments from pharmaceutical and medical device companies, with $1,431 received in 2024. These payments were reported across 121 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,157).
As a Medicare-enrolled provider, Ali has provided services to 927 Medicare beneficiaries, totaling 1,325 services with total Medicare billing of $98,092. Data is available for 3 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location League City, TX
- Active Since 04/19/2015
- Last Updated 05/17/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841687720
Products in Payments
- Korlym (Drug) $381.22
- Dexcom G6 Transmitter (Medical Supply) $294.84
- ZEPBOUND (Drug) $231.94
- Sogroya (Biological) $179.87
- SOLIQUA 100/33 (Biological) $172.98
- Kerendia (Drug) $153.90
- JARDIANCE (Drug) $144.85
- TOUJEO (Biological) $143.69
- Ozempic (Drug) $124.81
- ENTRESTO (Drug) $122.76
- Prolia (Biological) $120.32
- iLet Bionic Pancreas (Device) $100.36
- CeQur Simplicity (Device) $95.36
- Rybelsus (Drug) $80.67
- RECORLEV (Drug) $75.11
- MOUNJARO (Drug) $66.36
- XYOSTED (Drug) $50.74
- RAYALDEE (Drug) $48.74
- EVENITY (Biological) $45.65
- DALVANCE (Drug) $42.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in League City
Deepika Arora, Mbbs, MBBS
Internal Medicine — Payments: $15,797
Dr. David Washington, Md, MD
Internal Medicine — Payments: $3,491
Jason Gukhool, M.d, M.D
Internal Medicine — Payments: $2,510
Julia Zhang
Internal Medicine — Payments: $2,129
Joanna Nowak, Md, MD
Internal Medicine — Payments: $719.13
Cindy Chan, M.d, M.D
Internal Medicine — Payments: $633.15